切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DPP-4 - potassium channel - Glyoxalase I - Inward Rectifier Potassium (Kir) Channels

13件产品中的 1-10

页面
每页
清除全部
  1. Talabostat mesylate
    B3941 Talabostat mesylate
     2 Citation
    Target: DPP-4
    Summary: DPP4抑制剂
      ≥11.45 mg/mL
      ≥31 mg/mL
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Saxagliptin
    A8650 Saxagliptin
    中文名: 沙格列汀
    Target: DPP-4
    Summary: DPP4抑制剂
      ≥14.85 mg/mL
      ≥8.32 mg/mL
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. Teneligliptin hydrobromide
    A3865 Teneligliptin hydrobromide
    中文名: 氢溴酸替格列汀
    Target: DPP-4
    Summary: DDP4抑制剂
      ≥62.9 mg/mL
      ≥104.8 mg/mL
  9. Glyoxalase I inhibitor
    A3440 Glyoxalase I inhibitor
    Target: Glyoxalase I
    Summary: Glyoxalase I 抑制剂
      Soluble in DMSO
  10. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O

13件产品中的 1-10

页面
每页